AZ Rivierenland campus Rumst

Research site

Belgium 's Herenbaan 172, 2840 Reet, Belgium

1 trial recruiting
Neuroendocrine tumour · Gastroenteropancreatic neuroendocrine tumour disease · Pancreatic neuroendocrine tumour
Adult patients

About Specializations

AZ Rivierenland campus Rumst in Reet, Belgium specialises in clinical trials of conditions such as Neuroendocrine tumour, Gastroenteropancreatic neuroendocrine tumour disease, Pancreatic neuroendocrine tumour, Colon cancer stage III, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

's Herenbaan 1722840 ReetBelgium

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 5

More sites in Reet Belgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Neuroendocrine tumour+2

Recruiting

Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

Registered drugNo placebo

Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Everolimus
Sponsor:Antwerp University Hospital

Contact Research Centre

Colon cancer stage III+1

Not recruiting

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

Registered drug

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Antwerp University Hospital

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites